 | • レポートコード：B-GIR08C3165 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：Medical Care |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、イソクエン酸デヒドロゲナーゼ阻害剤の世界市場について調べ、まとめました。種類別セグメントは、IDH1変異型髄様悪性腫瘍、IDH2変異型髄様悪性腫瘍、その他等、用途別セグメントは、DH阻害剤、FLT3阻害剤、ハリネズミ経路阻害剤、その他等に区分しました。イソクエン酸デヒドロゲナーゼ阻害剤の世界市場概観、企業動向、企業別イソクエン酸デヒドロゲナーゼ阻害剤シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・イソクエン酸デヒドロゲナーゼ阻害剤の市場概観 ・イソクエン酸デヒドロゲナーゼ阻害剤の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・イソクエン酸デヒドロゲナーゼ阻害剤の企業別販売動向、市場シェア、市場集中度、競争動向 ・イソクエン酸デヒドロゲナーゼ阻害剤の世界市場規模 ・イソクエン酸デヒドロゲナーゼ阻害剤の北米市場分析（アメリカ、カナダ、メキシコ等） ・イソクエン酸デヒドロゲナーゼ阻害剤のアメリカ市場規模推移 ・イソクエン酸デヒドロゲナーゼ阻害剤のカナダ市場規模推移 ・イソクエン酸デヒドロゲナーゼ阻害剤のメキシコ市場規模推移 ・イソクエン酸デヒドロゲナーゼ阻害剤のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・イソクエン酸デヒドロゲナーゼ阻害剤のドイツ市場規模推移 ・イソクエン酸デヒドロゲナーゼ阻害剤のイギリス市場規模推移 ・イソクエン酸デヒドロゲナーゼ阻害剤のロシア市場規模推移 ・イソクエン酸デヒドロゲナーゼ阻害剤のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・イソクエン酸デヒドロゲナーゼ阻害剤の日本市場規模推移 ・イソクエン酸デヒドロゲナーゼ阻害剤の中国市場規模推移 ・イソクエン酸デヒドロゲナーゼ阻害剤の韓国市場規模推移 ・イソクエン酸デヒドロゲナーゼ阻害剤のインド市場規模推移 ・イソクエン酸デヒドロゲナーゼ阻害剤の東南アジア市場規模推移 ・イソクエン酸デヒドロゲナーゼ阻害剤の南米市場分析（ブラジル、アルゼンチン等） ・イソクエン酸デヒドロゲナーゼ阻害剤の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・イソクエン酸デヒドロゲナーゼ阻害剤の種類別分析/販売量、売上、市場シェア（IDH1変異型髄様悪性腫瘍、IDH2変異型髄様悪性腫瘍、その他） ・イソクエン酸デヒドロゲナーゼ阻害剤の用途別分析/市場規模（DH阻害剤、FLT3阻害剤、ハリネズミ経路阻害剤、その他） ・イソクエン酸デヒドロゲナーゼ阻害剤の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・イソクエン酸デヒドロゲナーゼ阻害剤の販売チャネル・代理店・貿易業者・ディーラー分析 |
Isocitrate dehydrogenase (IDH) (EC 1.1.1.42) and (EC 1.1.1.41) is an enzyme that catalyzes the oxidative decarboxylation of isocitrate, producing alpha-ketoglutarate (α-ketoglutarate) and CO2.
Scope of the Report:
Specific mutations in the isocitrate dehydrogenase gene IDH1 have been found in several brain tumors including astrocytoma, oligodendroglioma and glioblastoma multiforme, with mutations found in nearly all cases of secondary glioblastomas, which develop from lower-grade gliomas, but rarely in primary high-grade glioblastoma multiforme.Patients whose tumor had an IDH1 mutation had longer survival. Furthermore, mutations of IDH2 and IDH1 were found in up to 20% of cytogenetically normal acute myeloid leukemia (AML).These mutations are known to produce (D)-2-hydroxyglutarate from alpha-ketoglutarate.(D)-2-hydroxyglutarate accumulates to very high concentrations which inhibits the function of enzymes that are dependent on alpha-ketoglutarate.This leads to a hypermethylated state of DNA and histones, which results in different gene expression that can activate oncogenes and inactivate tumor-suppressor genes. Ultimately, this may lead to the types of cancer described above.Isocitrate dehydrogenase inhibition technology can be effectively applied to the cancer market.
The worldwide market for Isocitrate Dehydrogenase Inhibitors is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Isocitrate Dehydrogenase Inhibitors in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
AGIOS
Aslan Pharmaceuticals
Bayer
Beigene
Bristol-Myers Squibb
Celgene
Daiichi Sankyo
Philogen S.p.A.
Tesaro
Tragara/Adastra
Tocagen
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
IDH1 Mutant Medullary Malignant Tumor
IDH2 Mutant Medullary Malignant Tumor
Others
Market Segment by Applications, can be divided into
DH Inhibitor
FLT3 Inhibitor
Hedgehog Pathway Inhibitor
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Isocitrate Dehydrogenase Inhibitors product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Isocitrate Dehydrogenase Inhibitors, with price, sales, revenue and global market share of Isocitrate Dehydrogenase Inhibitors in 2017 and 2018.
Chapter 3, the Isocitrate Dehydrogenase Inhibitors competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Isocitrate Dehydrogenase Inhibitors breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Isocitrate Dehydrogenase Inhibitors market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Isocitrate Dehydrogenase Inhibitors sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Isocitrate Dehydrogenase Inhibitors Introduction
1.2 Market Analysis by Type
1.2.1 IDH1 Mutant Medullary Malignant Tumor
1.2.2 IDH2 Mutant Medullary Malignant Tumor
1.2.3 Others
1.3 Market Analysis by Applications
1.3.1 DH Inhibitor
1.3.2 FLT3 Inhibitor
1.3.3 Hedgehog Pathway Inhibitor
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AGIOS
2.1.1 Business Overview
2.1.2 Isocitrate Dehydrogenase Inhibitors Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AGIOS Isocitrate Dehydrogenase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Aslan Pharmaceuticals
2.2.1 Business Overview
2.2.2 Isocitrate Dehydrogenase Inhibitors Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Bayer
2.3.1 Business Overview
2.3.2 Isocitrate Dehydrogenase Inhibitors Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bayer Isocitrate Dehydrogenase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Beigene
2.4.1 Business Overview
2.4.2 Isocitrate Dehydrogenase Inhibitors Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Beigene Isocitrate Dehydrogenase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Bristol-Myers Squibb
2.5.1 Business Overview
2.5.2 Isocitrate Dehydrogenase Inhibitors Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Celgene
2.6.1 Business Overview
2.6.2 Isocitrate Dehydrogenase Inhibitors Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Celgene Isocitrate Dehydrogenase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Daiichi Sankyo
2.7.1 Business Overview
2.7.2 Isocitrate Dehydrogenase Inhibitors Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Philogen S.p.A.
2.8.1 Business Overview
2.8.2 Isocitrate Dehydrogenase Inhibitors Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Tesaro
2.9.1 Business Overview
2.9.2 Isocitrate Dehydrogenase Inhibitors Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Tesaro Isocitrate Dehydrogenase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Tragara/Adastra
2.10.1 Business Overview
2.10.2 Isocitrate Dehydrogenase Inhibitors Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Tocagen
2.11.1 Business Overview
2.11.2 Isocitrate Dehydrogenase Inhibitors Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Tocagen Isocitrate Dehydrogenase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Isocitrate Dehydrogenase Inhibitors Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Isocitrate Dehydrogenase Inhibitors Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Isocitrate Dehydrogenase Inhibitors Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Isocitrate Dehydrogenase Inhibitors Manufacturer Market Share in 2018
3.3.2 Top 6 Isocitrate Dehydrogenase Inhibitors Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Isocitrate Dehydrogenase Inhibitors Market Analysis by Regions
4.1 Global Isocitrate Dehydrogenase Inhibitors Sales, Revenue and Market Share by Regions
4.1.1 Global Isocitrate Dehydrogenase Inhibitors Sales and Market Share by Regions (2014-2019)
4.1.2 Global Isocitrate Dehydrogenase Inhibitors Revenue and Market Share by Regions (2014-2019)
4.2 North America Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
4.3 Europe Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
4.5 South America Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
5 North America Isocitrate Dehydrogenase Inhibitors by Country
5.1 North America Isocitrate Dehydrogenase Inhibitors Sales, Revenue and Market Share by Country
5.1.1 North America Isocitrate Dehydrogenase Inhibitors Sales and Market Share by Country (2014-2019)
5.1.2 North America Isocitrate Dehydrogenase Inhibitors Revenue and Market Share by Country (2014-2019)
5.2 United States Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
5.3 Canada Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
5.4 Mexico Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
6 Europe Isocitrate Dehydrogenase Inhibitors by Country
6.1 Europe Isocitrate Dehydrogenase Inhibitors Sales, Revenue and Market Share by Country
6.1.1 Europe Isocitrate Dehydrogenase Inhibitors Sales and Market Share by Country (2014-2019)
6.1.2 Europe Isocitrate Dehydrogenase Inhibitors Revenue and Market Share by Country (2014-2019)
6.2 Germany Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
6.3 UK Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
6.4 France Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
6.5 Russia Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
6.6 Italy Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
7 Asia-Pacific Isocitrate Dehydrogenase Inhibitors by Country
7.1 Asia-Pacific Isocitrate Dehydrogenase Inhibitors Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Isocitrate Dehydrogenase Inhibitors Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Isocitrate Dehydrogenase Inhibitors Revenue and Market Share by Country (2014-2019)
7.2 China Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
7.3 Japan Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
7.4 Korea Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
7.5 India Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
8 South America Isocitrate Dehydrogenase Inhibitors by Country
8.1 South America Isocitrate Dehydrogenase Inhibitors Sales, Revenue and Market Share by Country
8.1.1 South America Isocitrate Dehydrogenase Inhibitors Sales and Market Share by Country (2014-2019)
8.1.2 South America Isocitrate Dehydrogenase Inhibitors Revenue and Market Share by Country (2014-2019)
8.2 Brazil Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
8.3 Argentina Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
8.4 Colombia Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
9 Middle East and Africa Isocitrate Dehydrogenase Inhibitors by Countries
9.1 Middle East and Africa Isocitrate Dehydrogenase Inhibitors Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Isocitrate Dehydrogenase Inhibitors Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Isocitrate Dehydrogenase Inhibitors Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
9.3 Turkey Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
9.4 Egypt Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
9.5 Nigeria Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
9.6 South Africa Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
10 Global Isocitrate Dehydrogenase Inhibitors Market Segment by Type
10.1 Global Isocitrate Dehydrogenase Inhibitors Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Isocitrate Dehydrogenase Inhibitors Sales and Market Share by Type (2014-2019)
10.1.2 Global Isocitrate Dehydrogenase Inhibitors Revenue and Market Share by Type (2014-2019)
10.2 IDH1 Mutant Medullary Malignant Tumor Sales Growth and Price
10.2.1 Global IDH1 Mutant Medullary Malignant Tumor Sales Growth (2014-2019)
10.2.2 Global IDH1 Mutant Medullary Malignant Tumor Price (2014-2019)
10.3 IDH2 Mutant Medullary Malignant Tumor Sales Growth and Price
10.3.1 Global IDH2 Mutant Medullary Malignant Tumor Sales Growth (2014-2019)
10.3.2 Global IDH2 Mutant Medullary Malignant Tumor Price (2014-2019)
10.4 Others Sales Growth and Price
10.4.1 Global Others Sales Growth (2014-2019)
10.4.2 Global Others Price (2014-2019)
11 Global Isocitrate Dehydrogenase Inhibitors Market Segment by Application
11.1 Global Isocitrate Dehydrogenase Inhibitors Sales Market Share by Application (2014-2019)
11.2 DH Inhibitor Sales Growth (2014-2019)
11.3 FLT3 Inhibitor Sales Growth (2014-2019)
11.4 Hedgehog Pathway Inhibitor Sales Growth (2014-2019)
11.5 Others Sales Growth (2014-2019)
12 Isocitrate Dehydrogenase Inhibitors Market Forecast (2019-2024)
12.1 Global Isocitrate Dehydrogenase Inhibitors Sales, Revenue and Growth Rate (2019-2024)
12.2 Isocitrate Dehydrogenase Inhibitors Market Forecast by Regions (2019-2024)
12.2.1 North America Isocitrate Dehydrogenase Inhibitors Market Forecast (2019-2024)
12.2.2 Europe Isocitrate Dehydrogenase Inhibitors Market Forecast (2019-2024)
12.2.3 Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Forecast (2019-2024)
12.2.4 South America Isocitrate Dehydrogenase Inhibitors Market Forecast (2019-2024)
12.2.5 Middle East and Africa Isocitrate Dehydrogenase Inhibitors Market Forecast (2019-2024)
12.3 Isocitrate Dehydrogenase Inhibitors Market Forecast by Type (2019-2024)
12.3.1 Global Isocitrate Dehydrogenase Inhibitors Sales Forecast by Type (2019-2024)
12.3.2 Global Isocitrate Dehydrogenase Inhibitors Market Share Forecast by Type (2019-2024)
12.4 Isocitrate Dehydrogenase Inhibitors Market Forecast by Application (2019-2024)
12.4.1 Global Isocitrate Dehydrogenase Inhibitors Sales Forecast by Application (2019-2024)
12.4.2 Global Isocitrate Dehydrogenase Inhibitors Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Isocitrate Dehydrogenase Inhibitors Picture
Table Product Specifications of Isocitrate Dehydrogenase Inhibitors
Figure Global Sales Market Share of Isocitrate Dehydrogenase Inhibitors by Types in 2018
Table Isocitrate Dehydrogenase Inhibitors Types for Major Manufacturers
Figure IDH1 Mutant Medullary Malignant Tumor Picture
Figure IDH2 Mutant Medullary Malignant Tumor Picture
Figure Others Picture
Figure Isocitrate Dehydrogenase Inhibitors Sales Market Share by Applications in 2018
Figure DH Inhibitor Picture
Figure FLT3 Inhibitor Picture
Figure Hedgehog Pathway Inhibitor Picture
Figure Others Picture
Figure United States Isocitrate Dehydrogenase Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Isocitrate Dehydrogenase Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Isocitrate Dehydrogenase Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Isocitrate Dehydrogenase Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure France Isocitrate Dehydrogenase Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure UK Isocitrate Dehydrogenase Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Isocitrate Dehydrogenase Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Isocitrate Dehydrogenase Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure China Isocitrate Dehydrogenase Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Isocitrate Dehydrogenase Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Isocitrate Dehydrogenase Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure India Isocitrate Dehydrogenase Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Isocitrate Dehydrogenase Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Isocitrate Dehydrogenase Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Isocitrate Dehydrogenase Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Isocitrate Dehydrogenase Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Isocitrate Dehydrogenase Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Isocitrate Dehydrogenase Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Table AGIOS Basic Information, Manufacturing Base and Competitors
Table AGIOS Isocitrate Dehydrogenase Inhibitors Type and Applications
Table AGIOS Isocitrate Dehydrogenase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Aslan Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Type and Applications
Table Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Isocitrate Dehydrogenase Inhibitors Type and Applications
Table Bayer Isocitrate Dehydrogenase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Beigene Basic Information, Manufacturing Base and Competitors
Table Beigene Isocitrate Dehydrogenase Inhibitors Type and Applications
Table Beigene Isocitrate Dehydrogenase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Type and Applications
Table Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Celgene Basic Information, Manufacturing Base and Competitors
Table Celgene Isocitrate Dehydrogenase Inhibitors Type and Applications
Table Celgene Isocitrate Dehydrogenase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Type and Applications
Table Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Philogen S.p.A. Basic Information, Manufacturing Base and Competitors
Table Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Type and Applications
Table Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Tesaro Basic Information, Manufacturing Base and Competitors
Table Tesaro Isocitrate Dehydrogenase Inhibitors Type and Applications
Table Tesaro Isocitrate Dehydrogenase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Tragara/Adastra Basic Information, Manufacturing Base and Competitors
Table Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Type and Applications
Table Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Tocagen Basic Information, Manufacturing Base and Competitors
Table Tocagen Isocitrate Dehydrogenase Inhibitors Type and Applications
Table Tocagen Isocitrate Dehydrogenase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Isocitrate Dehydrogenase Inhibitors Sales by Manufacturer (2017-2018)
Figure Global Isocitrate Dehydrogenase Inhibitors Sales Market Share by Manufacturer in 2017
Figure Global Isocitrate Dehydrogenase Inhibitors Sales Market Share by Manufacturer in 2018
Table Global Isocitrate Dehydrogenase Inhibitors Revenue by Manufacturer (2017-2018)
Figure Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Manufacturer in 2017
Figure Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Manufacturer in 2018
Figure Top 3 Isocitrate Dehydrogenase Inhibitors Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Isocitrate Dehydrogenase Inhibitors Manufacturer (Revenue) Market Share in 2018
Figure Global Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
Figure Global Isocitrate Dehydrogenase Inhibitors Revenue and Growth Rate (2014-2019)
Table Global Isocitrate Dehydrogenase Inhibitors Sales by Regions (2014-2019)
Table Global Isocitrate Dehydrogenase Inhibitors Sales Market Share by Regions (2014-2019)
Table Global Isocitrate Dehydrogenase Inhibitors Revenue by Regions (2014-2019)
Figure Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Regions (2014-2019)
Figure Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Regions in 2018
Figure North America Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
Figure Europe Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
Figure South America Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
Figure North America Isocitrate Dehydrogenase Inhibitors Revenue and Growth Rate (2014-2019)
Table North America Isocitrate Dehydrogenase Inhibitors Sales by Countries (2014-2019)
Table North America Isocitrate Dehydrogenase Inhibitors Sales Market Share by Countries (2014-2019)
Figure North America Isocitrate Dehydrogenase Inhibitors Sales Market Share by Countries (2014-2019)
Figure North America Isocitrate Dehydrogenase Inhibitors Sales Market Share by Countries in 2018
Table North America Isocitrate Dehydrogenase Inhibitors Revenue by Countries (2014-2019)
Table North America Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Countries (2014-2019)
Figure North America Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Countries (2014-2019)
Figure North America Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Countries in 2018
Figure United States Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
Figure Canada Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
Figure Mexico Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
Figure Europe Isocitrate Dehydrogenase Inhibitors Revenue and Growth Rate (2014-2019)
Table Europe Isocitrate Dehydrogenase Inhibitors Sales by Countries (2014-2019)
Table Europe Isocitrate Dehydrogenase Inhibitors Sales Market Share by Countries (2014-2019)
Table Europe Isocitrate Dehydrogenase Inhibitors Revenue by Countries (2014-2019)
Figure Europe Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Countries (2014-2019)
Figure Europe Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Countries in 2018
Figure Germany Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
Figure UK Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
Figure France Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
Figure Russia Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
Figure Italy Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Isocitrate Dehydrogenase Inhibitors Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Isocitrate Dehydrogenase Inhibitors Sales by Countries (2014-2019)
Table Asia-Pacific Isocitrate Dehydrogenase Inhibitors Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Isocitrate Dehydrogenase Inhibitors Sales Market Share by Countries 2018
Table Asia-Pacific Isocitrate Dehydrogenase Inhibitors Revenue by Countries (2014-2019)
Figure Asia-Pacific Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Countries 2018
Figure China Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
Figure Japan Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
Figure Korea Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
Figure India Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
Figure Southeast Asia Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
Figure South America Isocitrate Dehydrogenase Inhibitors Revenue and Growth Rate (2014-2019)
Table South America Isocitrate Dehydrogenase Inhibitors Sales by Countries (2014-2019)
Table South America Isocitrate Dehydrogenase Inhibitors Sales Market Share by Countries (2014-2019)
Figure South America Isocitrate Dehydrogenase Inhibitors Sales Market Share by Countries in 2018
Table South America Isocitrate Dehydrogenase Inhibitors Revenue by Countries (2014-2019)
Table South America Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Countries (2014-2019)
Figure South America Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Countries in 2018
Figure Brazil Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
Figure Argentina Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
Figure Colombia Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Isocitrate Dehydrogenase Inhibitors Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Isocitrate Dehydrogenase Inhibitors Sales by Countries (2014-2019)
Table Middle East and Africa Isocitrate Dehydrogenase Inhibitors Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Isocitrate Dehydrogenase Inhibitors Sales Market Share by Countries in 2018
Table Middle East and Africa Isocitrate Dehydrogenase Inhibitors Revenue by Countries (2014-2019)
Table Middle East and Africa Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Countries in 2018
Figure Saudi Arabia Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
Figure UAE Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
Figure Egypt Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
Figure Nigeria Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
Figure South Africa Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2014-2019)
Table Global Isocitrate Dehydrogenase Inhibitors Sales by Type (2014-2019)
Table Global Isocitrate Dehydrogenase Inhibitors Sales Share by Type (2014-2019)
Table Global Isocitrate Dehydrogenase Inhibitors Revenue by Type (2014-2019)
Table Global Isocitrate Dehydrogenase Inhibitors Revenue Share by Type (2014-2019)
Figure Global IDH1 Mutant Medullary Malignant Tumor Sales Growth (2014-2019)
Figure Global IDH1 Mutant Medullary Malignant Tumor Price (2014-2019)
Figure Global IDH2 Mutant Medullary Malignant Tumor Sales Growth (2014-2019)
Figure Global IDH2 Mutant Medullary Malignant Tumor Price (2014-2019)
Figure Global Others Sales Growth (2014-2019)
Figure Global Others Price (2014-2019)
Table Global Isocitrate Dehydrogenase Inhibitors Sales by Application (2014-2019)
Table Global Isocitrate Dehydrogenase Inhibitors Sales Share by Application (2014-2019)
Figure Global DH Inhibitor Sales Growth (2014-2019)
Figure Global FLT3 Inhibitor Sales Growth (2014-2019)
Figure Global Hedgehog Pathway Inhibitor Sales Growth (2014-2019)
Figure Global Others Sales Growth (2014-2019)
Figure Global Isocitrate Dehydrogenase Inhibitors Sales, Revenue and Growth Rate (2019-2024)
Table Global Isocitrate Dehydrogenase Inhibitors Sales Forecast by Regions (2019-2024)
Table Global Isocitrate Dehydrogenase Inhibitors Market Share Forecast by Regions (2019-2024)
Figure North America Sales Isocitrate Dehydrogenase Inhibitors Market Forecast (2019-2024)
Figure Europe Sales Isocitrate Dehydrogenase Inhibitors Market Forecast (2019-2024)
Figure Asia-Pacific Sales Isocitrate Dehydrogenase Inhibitors Market Forecast (2019-2024)
Figure South America Sales Isocitrate Dehydrogenase Inhibitors Market Forecast (2019-2024)
Figure Middle East and Africa Sales Isocitrate Dehydrogenase Inhibitors Market Forecast (2019-2024)
Table Global Isocitrate Dehydrogenase Inhibitors Sales Forecast by Type (2019-2024)
Table Global Isocitrate Dehydrogenase Inhibitors Market Share Forecast by Type (2019-2024)
Table Global Isocitrate Dehydrogenase Inhibitors Sales Forecast by Application (2019-2024)
Table Global Isocitrate Dehydrogenase Inhibitors Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
プロテインキナーゼ阻害剤の世界市場予測 2024年：メーカー別、地域別、種類・用途別 Scope of the Report: The worldwide market for Protein Kinase Inhibitor is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Protein Kinase Inhibitor…- クロムミスト防止剤の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Chromium Mist Inhibitor is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Chromium Mist Inhibitor i…
- PD-1阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global PD-1 Inhibitor market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast …
- 世界のプラスミノーゲンアクチベーター阻害剤1市場2019 The global Plasminogen Activator Inhibitor 1 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Plasminogen Activator Inhibitor 1 market status and forecast, categorizes the global Plasminogen …
- 世界の血漿プロテアーゼC1阻害剤治療市場2019 The global Plasma Protease C1-inhibitor Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Plasma Protease C1-inhibitor Treatment market status and forecast, categorizes the global Pl…